Eric Topol· @EricTopol · X·· 3 小时前AI 评分38
AI 导读
长寿产品营销已失控，但FDA已有成熟的审批路径来要求所需证据。 一篇@ScienceMagazine政策论坛文章 “与其倾向于放松监管，不如将资源投入到验证终点和執行现有法规上，这才是最能服务公众、推进科学和促进创新的做法。” https://www.science.org/doi/10.1126/science.aei2427
正文
Longevity product marketing is out of control, but there are established FDA pathways for the evidence required to get approvals.
A @ScienceMagazine policy forum
"Rather than leaning into deregulation, dedicating resources to validating endpoints and to enforcing existing regulation is what will best serve the public, advance science, and promote innovation."
https://www.science.org/doi/10.1126/science.aei2427
来源：Eric Topol · x.com